Retatrutide (Pen)

The triple agonist outpacing everything before it.

weight lossglp-1triple agonistinjection pen

Pricing for this product is available to members. Create an account.

Retatrutide is the next generation of weight-loss peptides, a triple agonist that hits GLP-1, GIP and the glucagon receptor. Adding glucagon lifts your energy expenditure on top of appetite control, and early trials show fat loss that outpaces even tirzepatide. This 64 mg pre-filled pen is aimed at experienced users titrating carefully. It is still investigational, so dose conservatively and go slow.

What it's used for

✓Triple agonist: GLP-1, GIP and glucagon
✓Among the strongest fat loss in trials
✓Raises energy expenditure, not just appetite
✓64 mg multidose pre-filled pen

In stockweight loss

Pairs with

Best Seller

Xenogenix Tirzepatide pre-filled injection pen and box

30 mg · pre-filled penweight loss

Tirzepatide (Pen)

The dual-agonist behind the strongest weight loss to date.

Xenogenix Tirzepatide self-mix vial and bacteriostatic water

30 mg · self-mix vialweight loss

Tirzepatide (Vial)

The dual-agonist weight-loss peptide, as a self-mix vial.

Xenogenix Retatrutide self-mix vial and bacteriostatic water

32 mg · self-mix vialweight loss

Retatrutide (Vial)

The triple-agonist weight-loss peptide, as a self-mix vial.